TTY Biopharm: Clinical Trials

26 trials sponsored by TTY Biopharm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 unknown, 9 completed, 4 terminated, 1 active not recruiting. 12 Phase 2, 4 Phase 3, 3 Not applicable, 3 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 212Unknown 7, Completed 2, Terminated 2, Not yet recruiting 1
Phase 34Completed 3, Terminated 1
Not applicable3Completed 2, Unknown 1
Phase 13Completed 1, Terminated 1, Unknown 1
Phase 41Unknown 1

Follow TTY Biopharm: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II Study of Ultrasound and ctDNA Guided Neoadjuvant Systemic Therapy for Patients With HER2-positive Early Breast Cancer (UC HER Trial)
Lipo-Dox®, Cyclophosphamide, Trastuzumab (Herceptin) - HER-2 Positive Breast Cancer
Phase 2Not yet recruitingNational Taiwan University Hospital542026-04-302026-05-04
Evaluating the Treatment Outcomes of Tafasitamab in Patients With Relapsed/ Refractory Diffuse Large B-cell Lymphoma: a Real-world Evidence Study
Minjuvi - DLBCL
Active not recruitingTTY Biopharm502025-12-012026-07-16
A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection
Bacteremia Caused by Gram-Negative Bacteria, Bacterial Pneumonia
RecruitingTTY Biopharm4802025-11-262026-03-09
A Pharmacokinetic Study of Polymyxin B in Healthy Subjects and Subjects With Renal Insufficiency
Polymyxin B - Antibiotic Toxicity
Phase 1CompletedTTY Biopharm222022-07-262023-04-27
Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer
leucovorin, oxaliplatin, docetaxel, S-1 - Gastric Cancer, Gastric Adenocarcinoma
Phase 2UnknownNational Cheng-Kung University Hospital582021-12-102023-11-15
Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer
Nivolumab, Gemcitabine, Tegafur-Gimeracil-Oteracil - Stage IV Pancreatic Cancer
Phase 2UnknownNational Taiwan University Hospital382020-07-012020-05-06
A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan
S-1 - Resected Pancreatic Cancer, Pancreatic Cancer
Phase 2TerminatedTTY Biopharm362019-07-112021-12-06
S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer
Tegafur-gimeracil-oteracil potassium, Oxaliplatin, Irinotecan - Pancreatic Ductal Adenocarcinoma
Phase 2UnknownNational Taiwan University Hospital352017-11-012017-10-20
A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever
Lipo-AB® (amphotericin B) liposome - Neutropenia, Febrile
CompletedTTY Biopharm542016-05-242018-04-30
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma
Gemcitabine, Valproic acid, Valganciclovir - Nasopharyngeal Carcinoma
Phase 1UnknownChang Gung Memorial Hospital182016-05-012016-05-16
Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With H&N Cancer Who Receiving CCRT
Megestrol acetate (MA) 400 mg/day - Head and Neck Cancer
Phase 2UnknownTTY Biopharm1052015-05-012017-01-18
A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer
S-1/Gemcitabine - Advanced Biliary Tract Cancer(BTC)
Phase 2CompletedTTY Biopharm512015-04-012019-08-21
A Dose Titration Study of Fentanyl Buccal Soluble Film for Breakthrough Cancer Pain in Taiwan
Fentanyl buccal soluble film (FBSF) - Breakthrough Cancer Pain
Not applicableCompletedChang Gung Memorial Hospital362014-11-252018-09-13
Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances
sodium alginate, esomeprazole - Gastroesophageal Reflux Disease, Heartburn
Phase 4UnknownChang Gung Memorial Hospital3402014-11-012014-11-19
TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRC
S-1+leucovorin - Metastatic Colorectal Cancer
Phase 2CompletedTTY Biopharm412014-07-052018-05-07
Phase I Study of TS-1 With Concurrent Radiotherapy to Treat Pancreatic Cancer
S-1-CCRT - Metastatic Pancreatic Cancer
Phase 1TerminatedNational Taiwan University Hospital102013-10-012017-01-18
Efficacy and Safety of Alginos Oral Suspension to Treat Laryngopharyngeal Reflux
Sodium alginate, Placebo - Laryngopharyngeal Reflux
Phase 3CompletedTTY Biopharm802011-10-012015-06-08
A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer
TS-1/Cisplatin - Non-small-cell Lung Cancer (NSCLC)
Not applicableCompletedTTY Biopharm452011-03-012016-01-12
Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis
Liposomal amphotericin B, Amphotericin B-deoxycholate - Cryptococcal Meningitis
Not applicableUnknownTTY Biopharm842011-02-012014-05-12
A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients
Epirubicin+Cyclophosphamide, liposomal-doxorubicin+Cyclophosphamide - Breast Cancer
Phase 2UnknownTTY Biopharm2542010-06-012021-11-23

Showing 20 of 26. Sign in to see all of them.

Conditions studied

Breast Neoplasms (4)  ·  Pancreatic Neoplasms (4)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Bipolar Disorder (1)  ·  Carcinoma, Hepatocellular (1)  ·  Colorectal Neoplasms (1)  ·  Epstein-Barr Virus Infections (1)  ·  Febrile Neutropenia (1)  ·  Gastroesophageal Reflux (1)  ·  Head and Neck Neoplasms (1)  ·  Heartburn (1)  ·  Laryngopharyngeal Reflux (1)  ·  Meningitis, Cryptococcal (1)  ·  Multiple Acyl Coenzyme A Dehydrogenase Deficiency (1)  ·  Nasopharyngeal Carcinoma (1)

Interventions

S 1 (combination) (4)  ·  Gemcitabine (3)  ·  titanium silicide (3)  ·  Alginates (2)  ·  Amphotericin B (2)  ·  Docetaxel (2)  ·  Oxaliplatin (2)  ·  Valproic Acid (2)  ·  Cisplatin (1)  ·  Cyclophosphamide (1)  ·  Dextromethorphan (1)  ·  EC regimen (1)  ·  Esomeprazole (1)  ·  Irinotecan (1)  ·  Leucovorin (1)

Countries

Taiwan (23)  ·  Japan (1)  ·  Singapore (1)

Top investigators

Alex Chang (1)  ·  Cheng-Hsu Wang (1)  ·  Cheng-Jeng Tai, M.D. (1)  ·  Cheng-Lung Hsu, Physican (1)  ·  Cheng-Tang Chiu, M.D. (1)  ·  Chia Jui Yen, M.D., Ph.D. (1)  ·  Hsien-Kun Chang (1)  ·  Hung-Chih Hsu (1)  ·  Hung-Ming Wang, M.D. (1)  ·  I Shu Chen, M.D. (1)  ·  Li Yuan Bai, M.D., Ph.D. (1)  ·  Li-Tzong Chen, M.D Ph.D. (1)  ·  Li-Tzong Chen, M.D. (1)  ·  Ming Huang Chen, M.D., Ph.D. (1)

Results publications

PMID 23547081, PMID 16822992, PMID 21444866, PMID 23763511, PMID 26416517, PMID 26768369, PMID 28210843, PMID 29119276, PMID 30982686, PMID 31765987, PMID 32463975, PMID 32721110, PMID 39673151, PMID 41113977, PMID 41543393